Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Advances in Cellular Assays & Cell Culture

Advances in Cellular Assays & Cell Culture Agenda



Co-Located Conference Agendas

Advances in Cellular Assays & Cell Culture | High Content Analysis | Advances in Automation & Robotics | Advances in NGS & Big Data | Advances in qPCR and dPCR | 

Print Agenda

Wednesday, 14 May 2014

08:00

Registration


3D Cell Culture
Session SponsorsSession Sponsor

09:15

Establishment and Characterization of 3D Culture Systems as Preclinical in vitro Models of Human Colorectal Cancer
Manuele Muraro, Research Fellow, University Hospital Basel, Switzerland

We have developed innovative 3D systems for the culture of human colorectal cancer (CRC) mimicking in-vitro the behavior of cells within tissues. These systems could be used as platforms for anticancer drug evaluation.

10:00

Coffee and Networking in Exhibiton Hall

10:45

Anthony Mitchell DaviesKeynote Presentation

Advanced Cell Culture and Assay Systems for Biomedical Research
Anthony Mitchell Davies, Director, Trinity College Dublin, Ireland

Currently one the biggest drivers in the field is the need to improve the relevance of the cell based assays and culture systems, to achieve these aims many are turning their attention to the use of primary cells and/or 3 dimensional cellular assay models.  In this presentation we will for the first time report a new range of engineered cellular assay and culture systems that will closer mimic the cellular micro-environments found in vivo and describe how these can be used in conjunction with the very latest cellular analysis technologies to gain new insights into cellular function and disease.

11:45

3D Organotypic Liver Cultures and their Application in Predictive Toxicology
Fozia Noor, Biochemical Engineer, Saarland University, Germany

I will present 3D-cultures of liver cells for the long-term maintenance of liver like functions. We use metabolomics for the characterization of these cultures under serum-free conditions. These cultures can be used for pharmacologically relevant acute and chronic toxicity assessments. 

12:30

Evercyte GmbHTechnology Spotlight:
Urine Derived Cells for Cellular Assays
Johannes Grillari, Chief Scientific Officer/Co Founder, Evercyte GmbH

Non-invasively obtained human cell cultures from any consenting individual can be established using urine a source for cells. Here we summarize our knowledge on urine derived cells from kidney epithelial to iPS cells.

12:45

Lunch and Networking in Exhibition Hall

13:30

Poster Viewing Session


Cellular Capture and Purification Methodologies

14:00

Klaus PantelKeynote Presentation

Circulating Tumor Cells as Liquid Biopsy for Cancer Patients
Klaus Pantel, Chairman, Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Germany

The molecular analysis of CTC isolated from peripheral blood samples as “liquid biopsy” will reveal characteristics of metastatic cancer cells. This information can be used as companion diagnostics to improve the stratification of therapies and to obtain insights into therapy-induced selection of cancer cells.

15:00

A Potentially Scalable Method for the Harvesting of hMSCs from Microcarriers: Initial Results
Qasim Rafiq, Research Fellow, Loughbrough University, United Kingdom

Whilst much research investigating hMSC culture on microcarriers has focused on growth, much less involves their harvesting for passaging or as a step towards cryopreservation and storage. A successful new harvesting method has recently been outlined by us for cells grown on SoloHill microcarriers in a 5 L bioreactor. Here, this new method is set out in detail and it applicability for large scale culture discussed.

15:45

Coffee and Networking in Exhibiton Hall

16:30

Detection and Characterization of Viable Circulating Tumor Cells
Catherine Alix-Panabieres, Associate Professor, University Medical Center of Montpellier, France


Preventing Cell Line Cross Contamination
Session SponsorsSession Sponsor

17:15

Diagnosis and Prevention of Cell Line Cross Contamination; Causes, Identification and Prevention
John Masters, Professor, University College London, United Kingdom

Up to 20% of human cell lines are derived from a different individual or species to that claimed. The presentation will describe how poor tissue culture practice can result in cross-contamination, the use of STR profiling to identify it and methods for preventing it happening in the laboratory.

18:00

End of Day One

Thursday, 15 May 2014


Application of Cell Culture Technologies
Session SponsorsSession Sponsor

09:00

Dario MarchettiKeynote Presentation

Circulating Tumor Cells of Breast Cancer: Basic Research and Clinical Applications
Dario Marchetti, Endowed Professor, Baylor College of Medicine, United States of America

Identification of e signature in breast cancer CTCs competent for brain metastasis in xenografts.  Analyses of brain metastatic capabilities, frequency, and cell quantitation in EpCAM-negative  CTCs overexpressing this signature.

10:00

Coffee and Networking in Exhibiton Hall

10:45

Scale-down Protocols for Assessing the Impact of Stresses from Agitation on Animal Cell Cultures; Protein Production and Quality
Alvin Nienow, Professor, University of Birmingham, United Kingdom

Please note that this presentation will be given by Qasim Rafiq on behalf of Alvin Nienow.

Three studies of four CHO cell cultures in stirred bench scale bioreactors and in a microbioreactor, ambrTM, will be discussed. These scale-down protocols showed that at high mean specific energy dissipation rates (‘high shear’) up to ~ 50 times those normally used in commercial culture, neither cell density, protein yield or protein quality were reduced.

11:30

Process Tools for Cell Culture Expansion and Assays
Manuel Carrondo, Professor, Universidade Nova de Lisboa, Portugal

Since the early nineties, IBET has been developing bioreaction processes to cultivate primary cells under long term batch, semi batch or perfusion conditions. Such expertise was later used to expand and tightly differentiate stem cells (hESC, Cardiac, iPS...). Finally, tools for long term experimentation or drug testing for brain, liver or cancer cell models have been implemented. Universal features and specifities of the different systems will be reviewed and their relevance highlighted.

12:15

Lunch and Networking in Exhibition Hall

13:30

Poster Viewing Session


Optimising Cell Line Development
Session SponsorsSession Sponsor

14:15

Insights from Metabolomics in Compartmented Cells
Ralf Takors, Director, University of Stuttgart, Germany

Recent achievements of metabolomic tool development will be presented especially focusing on challenges caused by cellular compartmentation. Contributions to compartment-specific metabolite analysis will be shown. Evidences for intracellular protein degradation will be given.

15:00

Close of Conference


Add to Calendar ▼2014-05-14 00:00:002014-05-15 00:00:00Europe/LondonAdvances in Cellular Assays and Cell CultureAdvances in Cellular Assays and Cell Culture in Barcelona, SpainBarcelona, SpainSELECTBIOenquiries@selectbiosciences.com